header image

[Sign Up Now] to Receive Our FREE Daily SCVTV-SCVNews Digest by E-Mail

Inside
Weather


 
Calendar
Today in
S.C.V. History
March 15
1942 - Emery Whilton's Florafaunium opens in Lebec [story]
Florafaunium


In partnership with the Liberian government, the National Institute of Allergy and Infectious Diseases (NIAID) launched a clinical trial Friday to obtain safety and efficacy data on the investigational drug ZMapp as a treatment for Ebola virus disease. The study, which will be conducted in Liberia and the United States, is a randomized controlled trial enrolling adults and children with known Ebola virus infection.

“Although ZMapp has been used to treat several Ebola-infected patients in recent months, we cannot determine if the drug actually benefitted those patients because it was not administered within the context of a clinical trial,” said Anthony S. Fauci, M.D., director of the NIAID, at the National Institutes of Health (NIH). “This clinical trial will help us determine if ZMapp and other treatments are safe and effective for use in the current devastating outbreak in West Africa as well as in future outbreaks.”

Ebola virus buds from the surface of a Vero cell from the African green-monkey kidney epithelial cell line. Photo: National Institute of Allergy and Infectious Diseases.

Ebola virus buds from the surface of a Vero cell from the African green-monkey kidney epithelial cell line. Photo: National Institute of Allergy and Infectious Diseases.

ZMapp, developed by Mapp Biopharmaceutical Inc., based in San Diego, is composed of three different proteins called monoclonal antibodies. ZMapp is designed to prevent the progression of Ebola virus disease within the body by targeting the main surface protein of the Ebola virus. The antibodies comprising ZMapp are produced in tobacco plants specially bioengineered to produce large quantities of these proteins. Studies in nonhuman primates demonstrated that ZMapp has strong antiviral activity and rescued the animals from death as late as five days after infection with Zaire ebolavirus. The drug has not yet been tested in human clinical trials, but was administered under emergency use authorization to nine infected patients in Africa, the United States, and Western Europe.

The trial will be led by co-principal investigators Richard T. Davey, Jr., M.D., deputy clinical director of NIAID’s Division of Intramural Research, and Moses Massaquoi, M.D., National Chair for Case Management at the Ebola Incident Management System in Monrovia.  The trial will enroll adults and children of any age who have been admitted to Ebola treatment units in Liberia, health care workers who were infected with Ebola virus in West Africa and have returned to the United States for treatment, and adults and children who may have acquired Ebola infection in the United States through secondary transmission. All participants will provide informed consent prior to enrollment. Treatment centers in Monrovia, Liberia, will include the ELWA 2 Ebola treatment unit and the Monrovia Medical Unit—staffed by the Commissioned Corps of the U.S. Public Health Service. The NIH Clinical Center in Bethesda, Maryland will serve as a treatment center in the U.S. Additional trial sites under consideration in the U.S. include the Walter Reed National Military Medical Center in Bethesda, Maryland, Emory University Hospital in Atlanta, and the University of Nebraska Medical Center in Omaha, Nebraska.

All participants will receive the optimized standard of care for treating Ebola infection, which includes providing intravenous fluids, balancing electrolytes, maintaining oxygen status and blood pressure and treating other infections if they occur. Participants will then be assigned randomly to one of two groups: the first group, which will act as the control, will continue to receive the current optimized standard of care. The second group will receive the optimized standard of care plus three separate intravenous infusions of ZMapp administered three days apart. The total dose of ZMapp at each infusion will depend on the weight of the participant. Study participants will be monitored up to 30 days following discharge from the hospital and may return for outpatient visits for additional follow up.

Researchers designed the study protocol to include a series of two-arm comparisons (the first being ZMapp compared to the current standard of care) to establish a framework to evaluate multiple potential Ebola treatments in the future. If one investigational treatment proves to be statistically more effective, it will then become the basis of the new standard of care against which additional investigational Ebola interventions could be tested and compared. Each experimental therapy will be examined in up to 100 participants per arm. If scientists are unable to establish a significant difference after enrolling 100 participants per arm, then that particular treatment will be declared ineffective and scientists will begin testing the next therapy. These additional treatments may also include the following:

* Tekmira siRNA from Tekmira Pharmaceuticals Corp., based in Burnaby, British Columbia

* Favipiravir from Toyama Chemical Co. LTD, based in Tokyo, Japan

* Convalescent or post-immunization plasma collected from recent Ebola infection survivors. It is possible that this category could potentially be expanded to include plasma donors who have participated in Phase 1 Ebola vaccine clinical trials and whose plasma shows high neutralizing activity against the virus.

* BCX4430 from BioCryst, based in Durham, North Carolina

* AVI-7537 from Sarepta, based in Cambridge, Massachusetts

NIH is collaborating with experts from the University of Minnesota; Leidos Biomedical Research Inc.; Emory University Hospital; the University of Nebraska Medical Center; the Centers for Disease Control and Prevention; the U.S. Food and Drug Administration; the Uniformed Services University of the Health Sciences; and the Walter Reed National Military Medical Center to conduct this trial. The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services, is funding the production of ZMapp. The trial is expected to conclude in December 2016. Given the current decline in the number of new Ebola cases in Liberia, study investigators anticipate the need for flexibility in the conduct and design of the trial to address the changing nature of the outbreak in West Africa. Consideration will also be given to other sites in the outbreak region that express interest.

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.

About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

Comment On This Story
COMMENT POLICY: We welcome comments from individuals and businesses. All comments are moderated. Comments are subject to rejection if they are vulgar, combative, or in poor taste.
REAL NAMES ONLY: All posters must use their real individual or business name. This applies equally to Twitter account holders who use a nickname.

No Comments

    Leave a Comment


    SCV NewsBreak
    Current Time 0:00
    /
    Duration Time 0:00
    Loaded: 0%
    Progress: 0%
    Stream TypeLIVE
    Remaining Time -0:00
     
    1x
    LOCAL NEWS HEADLINES
    Friday, Mar 14, 2025
    March 15: Lumpia Eating Contest at Island Pacific Santa Clarita
    Island Pacific Santa Clarita is gearing up for a celebration of National Lumpia Day with a lumpia-eating contest on Saturday, March 15, from 3-6:30 p.m.
    Friday, Mar 14, 2025
    March 26: SCV Water Hosts Public Workshop on Water Use Efficiency Plan
    In support of “Making Water Conservation a California Way of Life,” the Santa Clarita Valley Water Agency is developing a Water Use Efficiency Strategic Plan to establish a comprehensive water conservation strategy.
    Friday, Mar 14, 2025
    April 5: Annual Walk 4 MHF Help Kids Fight Cancer at Central Park
    The Michael Hoefflin Foundation for Children’s Cancer invites the community to join the annual "Walk 4 MHF Help Kids Fight Cancer" to help raise awareness and support local families affected by childhood cancer.
    Keep Up With Our Facebook

    Latest Additions to SCVNews.com
    1942 - Emery Whilton's Florafaunium opens in Lebec [story]
    Florafaunium
    Today in SCV History (March 15)
    After the January wildfires, the county began a review to assess our evacuation policies and emergency alert systems. The state has also commissioned a review of our preparedness efforts, immediate response to the fires and the recovery time frame of the incident.
    Kathryn Barger | Wildfire Analysis
    Island Pacific Santa Clarita is gearing up for a celebration of National Lumpia Day with a lumpia-eating contest on Saturday, March 15, from 3-6:30 p.m.
    March 15: Lumpia Eating Contest at Island Pacific Santa Clarita
    The regular meeting of the Saugus Union School District Governing Board of Trustees will be held Tuesday, March 18 beginning at 6:30 p.m.
    March 18: Saugus School Board to Receive Measure EE Annual Report
    After a successful pilot program in the Saugus Union School District, School Day Café has expanded the use of a new, eco-friendly serving tray option across all Santa Clarita Valley elementary schools.
    SCV Elementary School Lunches Offered on Eco-friendly Serving Trays
    In support of “Making Water Conservation a California Way of Life,” the Santa Clarita Valley Water Agency is developing a Water Use Efficiency Strategic Plan to establish a comprehensive water conservation strategy.
    March 26: SCV Water Hosts Public Workshop on Water Use Efficiency Plan
    College of the Canyons Women's Tennis got back in the win column with an 8-1 conference road win at Glendale College.
    Canyons Gets Back in the Win Column 8-1 at Glendale
    The Michael Hoefflin Foundation for Children’s Cancer invites the community to join the annual "Walk 4 MHF Help Kids Fight Cancer" to help raise awareness and support local families affected by childhood cancer.
    April 5: Annual Walk 4 MHF Help Kids Fight Cancer at Central Park
    The Santa Clarita Valley Historical Society has announced that the St. Francis Dam Tour scheduled for Saturday, March 15 has been postponed until Saturday, April 26.
    March 15: St. Francis Dam Tour Postponed Due to Rain
    The city of Santa Clarita is enhancing local roadways with the upcoming 2024-2025 Citywide Major Thoroughfare Median Refurbishment Project on Plum Canyon Road.
    City of Santa Clarita to Refurbish Plum Canyon Road Medians
    The Santa Clarita Valley Senior Center is preparing for the annual fundraising Celebrity Waiter Dinner to be held Saturday, April 26 at the Bella Vida Senior Center.
    April 26: Celebrity Waiter Dinner to Feature ‘Broadway Lights’ Theme
    2000 - Time capsule buried at Newhall Metrolink station [Station Grand Opening Video]
    Newhall Metrolink
    As you drive through Santa Clarita, you may have noticed something exciting, new projects are taking shape all around the city.
    Patsy Ayala | From Groundbreakings to Grand Openings
    The Soroptimist International of Greater Santa Clarita Valley 16th Annual Wine Affair: Wine, Beer and Cheer Big Hat Bash will be held Sunday, April 6 on Main Street in Old Town Newhall from noon to 5 p.m.
    April 6: The 16th Annual Wine Affair Big Hat Bash
    The city of Santa Clarita's art exhibition, "Saddle Up Santa Clarita" will run through Wednesday, May 14 at Santa Clarita City Hall, 23920 Valencia Blvd., Valencia, CA 91355.
    ‘Saddle Up Santa Clarita’ Art Exhibition in City Hall
    The William S. Hart Union High School District has announced that 10 high school seniors have been named National Merit Scholarship Finalists in the 2025 National Merit Scholarship Program.
    Hart District Announces National Merit Scholarship Finalists
    The Master's University Theater Arts presents 'The Importance of Being Earnest' by Oscar Wilde Fridays and Saturdays, March 21-29 at The Master's University, Music Recital Hall at 24736 Quigley Canyon Road, Santa Clarita, CA 91321.
    March 21-29: TMU Theater Arts Presents ‘The Importance of Being Earnest’
    Beginning Monday, March 17, at 6 a.m., Jet will be hosting “Jet into Work,” on 88.5-FM, The SoCal Sound which will lend a fun and upbeat start to listeners’ mornings.
    The SoCal Sound to Present ‘Jet into Work’ Radio Show
    Safely dispose of household hazardous waste and electronic waste for free 9 a.m.- 3 p.m. Saturday, April 5 at the College of the Canyons Valencia Campus, 26455 Rockwell Canyon Road, Santa Clarita, CA 91355.
    April 5: Free HHW, E-Waste Disposal at COC
    The Music Center has announced 113 of Southern California’s most talented high school students have advanced in The Music Center’s 37th Annual Spotlight program, which includes three students from the Santa Clarita Valley.
    Three from SCV Earn Music Center Spotlight Recognition
    The track and field teams at The Master's University began their 2025 outdoor campaign at the Occidental Spring Break Classic on Saturday, March 8. Multiple qualifiers were added and a school record fell in the men's 4x100m relay.
    TMU Track Opens Outdoor Season at Oxy
    Assemblywoman Pilar Schiavo has announced the introduction of the Roads to Resilience Act, AB 1132, a piece of legislation designed to prioritize the needs of communities disproportionately impacted by climate disasters.
    Schiavo Introduces Bill to Improve Evacuation in At-Risk Areas
    College of the Canyons baseball claimed its first conference win in a 10-5 affair over Citrus College at Mike Gillespie Field on Tuesday, March 10.
    Cougars Pick Up First Conference Win 10-5 Over Citrus
    Opera America, a nonprofit that supports opera in the United States, recently announced the 2025 recipients of two of its prestigious distinctions: the 2025 Robert L.B. Tobin Director-Designer Prize and the Discovery Grants from its Opera Grants for Women Composers program.
    CalArtians Named Opera America 2025 Prize Winners, Grantees
    SCVNews.com